Exhibit 16.1
November 13, 2018
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Commissioners:
We have read AIT Therapeutics, Inc.’s statements pertaining to our firm included under Item 4.01 of its Form 8-K filed on November 13, 2018 and we agree with such statements concerning our firm. We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ Kost Forer Gabbay & Kasierer
Kost Forer Gabbay & Kasierer,
A member of Ernst & Young Global